| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/06/2001 | US6183740 Recombinant bacterial phytases and uses thereof |
| 02/06/2001 | CA2314798A1 1,2,4,5-tetrahydro-benzo[d]azepin derivatives |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/06/2001 | CA2024789C Compounds for the treatment of inflammation and allergy |
| 02/05/2001 | CA2314867A1 2,7-substituted octahydro-1h-pyrido¬1,2-a|pyrazine derivatives as ligands for serotonin receptors |
| 02/05/2001 | CA2309313A1 Stimulation of the immune response by human dendritic cell manipulation |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | WO2001007475A1 Novel peptides |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007441A1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES |
| 02/01/2001 | WO2001007440A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | WO2001007424A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 02/01/2001 | WO2001007417A1 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 02/01/2001 | WO2001007406A1 Novel amide derivatives |
| 02/01/2001 | WO2001007098A2 A device and method for performing a biological modification of a fluid |
| 02/01/2001 | WO2001007077A1 Antiulcer agents |
| 02/01/2001 | WO2001007076A1 Use of interleukin-11 to treat gastrointestinal disorders |
| 02/01/2001 | WO2001007074A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007069A1 In vivo induction for enhanced function of isolated hepatocytes |
| 02/01/2001 | WO2001007062A1 A synergistic composition for the treatment of liver and liver associated ailments and a process for preparing the same |
| 02/01/2001 | WO2001007057A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/01/2001 | WO2001007036A1 BICYCLIC ANTAGONISTS SELECTIVE FOR THE αvβ3 INTEGRIN |
| 02/01/2001 | WO2001007035A1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 02/01/2001 | WO2001007032A1 Th2 differentiation inhibitors |
| 02/01/2001 | WO2001006984A2 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2000063215A3 Indazole derivatives, preparation and therapeutic application thereof |
| 02/01/2001 | WO2000051583A3 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists |
| 02/01/2001 | WO2000050048A3 Bone marrow transplantation for hepatic regeneration and repair |
| 02/01/2001 | WO2000049043A3 Human lipid-associated proteins |
| 02/01/2001 | WO2000047194A3 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | CA2696819A1 Ghrelin related peptides |
| 02/01/2001 | CA2383017A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380226A1 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | CA2380181A1 8-phenyl-6,9-dihydro-¬1,2,4|triazolo¬3,4-i|purin-5-one derivatives |
| 02/01/2001 | CA2379937A1 A device and method for performing a biological modification of a fluid |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2378860A1 Bicyclic antagonists selective for the .alpha.v.beta.3 integrin |
| 02/01/2001 | CA2378845A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | CA2378395A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/01/2001 | CA2375982A1 Th2 differentiation inhibitors |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 02/01/2001 | CA2345920A1 Use of interleukin-11 to treat gastrointestinal disorders |
| 01/31/2001 | EP1072609A2 Cytoprotective agents comprising prosaposin-related peptides |
| 01/31/2001 | EP1072601A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072592A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072587A1 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 01/31/2001 | EP1072271A2 Selective immune down regulation (SIDR) mediated transplantation processes |
| 01/31/2001 | EP1072254A1 Food compositions, compositions for oral cavity and medicinal compositions for preventing or treating periodontosis and method for preventing or treating periodontosis |
| 01/31/2001 | EP1072253A1 Oral compositions |
| 01/31/2001 | EP1071781A1 B-cell growth factor related protein |
| 01/31/2001 | EP1071755A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep |
| 01/31/2001 | EP1071718A1 Matrix binding factor |
| 01/31/2001 | EP1071708A1 Edg family gene, human h218 |
| 01/31/2001 | EP1071702A1 Fatty acid derivatives of bile acids and bile acid derivatives |
| 01/31/2001 | EP1071701A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 01/31/2001 | EP1071680A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/31/2001 | EP1071655A1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 01/31/2001 | EP1071455A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 01/31/2001 | EP1071440A1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 01/31/2001 | EP1071433A2 Pharmaceutical composition |
| 01/31/2001 | EP1071432A1 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine |
| 01/31/2001 | EP1071423A1 Antagonists of gonadotropin releasing hormone |
| 01/31/2001 | EP1071417A1 Use of cannabinoids as anti-inflammatory agents |
| 01/31/2001 | EP1071414A1 Compounds and methods for treating mitochondria-associated diseases |
| 01/31/2001 | EP1071412A2 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them |
| 01/31/2001 | CN1282372A Mammalian sytokine-like polypeptide-10 |
| 01/31/2001 | CN1282321A Potassium channel openers |
| 01/31/2001 | CN1281724A Yantongzhi medicine for curing tooth-ache |
| 01/31/2001 | CN1281723A Tongfu Jianzang overwintered watermelon juice processing method |
| 01/31/2001 | CN1281714A Chinese medicine prescription for curing lithous diseases and its preparation process |
| 01/31/2001 | CN1281713A Weitong capsule for curing stomach-ache |
| 01/31/2001 | CN1281708A Medicine for curing stomatocace and its preparation method |
| 01/31/2001 | CN1281707A Chinese Patent medicine with function of invigorating spleen |
| 01/31/2001 | CN1281705A Yugan pill for curing hepatitis and ascites due to cirrhosis |
| 01/31/2001 | CN1281701A New medicine for curing chronic hepatitis B and its preparation method |
| 01/31/2001 | CN1281697A Multifunctional medicine |
| 01/31/2001 | CN1281696A Oral liquor for curing duodenal ulcer |
| 01/31/2001 | CN1061350C 2.7-substituted octahydro-pyrrolo (1.2-A) pyrazine derivatives |
| 01/31/2001 | CN1061341C 1-amino-ethylindole-derivatives |
| 01/31/2001 | CN1061263C Health-care medicinal liquor for curing stomach disease |
| 01/31/2001 | CN1061249C Medicine for curing hepatitis B |
| 01/31/2001 | CN1061246C Medicine for treating alimentary canal system disease |
| 01/31/2001 | CN1061245C Crude herb moxibustion plaster |
| 01/31/2001 | CN1061244C Medicine for treating hepatic disease |
| 01/31/2001 | CN1061232C Medical composition for curing gastritis and ulcer |
| 01/31/2001 | CN1061229C Fluorinated foam agent |
| 01/30/2001 | US6180671 Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected |
| 01/30/2001 | US6180647 Gastrointestinal disorders; nervous system disorders |
| 01/30/2001 | US6180644 Immunotherapeutic agents |
| 01/30/2001 | US6180643 Antagonist of interleukins, tumor necrosis factor |
| 01/30/2001 | US6180635 Novel thieno(2,3-d)pyrimidinediones which exhibit pharmacological activity, in particular immunosuppressive activity; treating allograft rejection |
| 01/30/2001 | US6180631 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 01/30/2001 | US6180621 Administering to warm-blooded animals for treatment and prevention of infectious diseases caused by helicobacter pylori |